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ABSTRACT
Information about the external world is conveyed by the nervous system via
specialized sensory organs such as the vomeronasal organ (VNO). The VNO is crucial
for pheromone detection and the regulation of social behavior in many mammals. Recent
research has shown that purinergic signaling pathways in the VNO play a role in the
chemosensory activity of the organ. There are two families of purinergic receptors that
may be involved in this activity, P2X and P2Y. We hypothesized that the vomeronasal
sensory neurons express both P2X and P2Y receptors which, when activated by ATP or
other purine/pyrimidine nucleotides, work to maintain homeostasis and assist in signal
transduction in the tissue. This hypothesis was partially addressed using reverse
transcription polymerase chain reaction (RT-PCR), immunohistochemistry, and
immunocytochemistry to determine where P2X receptors are expressed and if P2Y
receptors are expressed in the mouse VNO. RT-PCR results suggested that there is gene
expression of P2Y1, P2Y2, P2Y6, P2X1, and P2X3 receptors in the tissue. A selection of
the more commonly expressed purinergic receptors explored with immunohistochemistry
indicated that P2Y1, P2Y2, and P2X1 receptors are widely expressed throughout the
VNO, including expression in the sensory and non-sensory epithelia.
Immunocytochemistry results demonstrated expression of P2Y1 and P2Y2 receptors on
the vomeronasal sensory neurons, further supporting our hypothesis that the purinergic
receptors play a role in signal transduction. In conclusion, our data strongly support the
hypothesis that there are purinergic receptors present in the VNO of mice and are in
agreement with our previous data showing purinergic receptor-mediated modulation of
chemosensory signal transduction in vomeronasal sensory neurons.
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INTRODUCTION
Pheromone Signaling and the Vomeronasal Organ
Pheromones are a powerful and ubiquitous form of communication and molecular
control among species spanning every animal phylum, including single-cell organisms.
They are commonly defined as secreted or excreted chemical signals that trigger a
behavioral response in another member of the same species (Karlson and Luscher, 1959).
Recent research suggests that pheromones also induce endocrine responses, and ongoing
study will continue to determine the extent of the impact of pheromone signaling (Dulac
and Torello, 2003). Extensive study on the characterization of pheromones has
demonstrated that they exist as a wide variety of signaling molecules with many chemical
forms, including proteins and other small molecules (Brennan and Zufall, 2006). While
they have been classically defined as nonvolatile (unable to disperse as a vapor), recent
research has again demonstrated that the functional characteristics may be far more
complex, with nonvolatile and volatile forms now being recognized as pheromones
(Stowers and Marton, 2005). Two major factors that determine pheromones’ volatility in
the air and solubility in water are their size and polarity, with the substances often being
released in sweat and urine (Karlson and Luscher, 1959, Brennan and Zufall, 2006).
In mammals, the chemosensory structure known as the vomeronasal organ (VNO)
contains receptors that are specialized to receive and transmit pheromone signals. The
VNO was first identified in 1813 by Danish anatomist Ludvig Jacobson who believed it
to be a secretory organ (Doving and Trotier, 1998). Over the past twenty years extensive
study has revealed that the VNO is in fact an accessory olfactory organ that is part of the
larger olfactory system (

-Marcos, 2003). This system includes the
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main olfactory epithelium (MOE), the septal organ, and the Grüneberg ganglion, in
addition to the VNO (Eisthen, 1997,

-Marcos, 2003). Although

pheromone detection has been demonstrated in other tissues such as the MOE, in which
around 5% of olfactory neurons are responsive to pheromones, the VNO is highly
specialized with the vast majority of the vomeronasal sensory neurons (VSNs)
responding to pheromones (

-Marcos, 2003, Oshimoto et al., 2013).

Detailed structural information on the VNO is now available, and its signal transduction
mechanisms continue to be elucidated. The critical role it plays in regulating behavior
through the transduction of pheromones is also well documented (

-

Marcos, 2003).
Pheromone signal transduction by the VNO plays an important role in regulating
the behavior and activity of mammals. The endocrine responses initiated through
pheromone signaling can have long term effects, while behavioral responses are often
rapid and transient in nature (Dulac and Torello, 2003). An example of the pheromonal
regulation of endocrine functions in mice is the modification of the hypothalamicpituitary axis upon the chemotransduction of male and female pheromones. When
exposed to male pheromones a female mouse will experience an increase in luteinizing
hormone and a decrease in prolactin as regulated by the hypothalamic-pituitary axis,
while exposure to female pheromones will lead to an increase in prolactin in other
female mice (Keverne and de la Riva, 1982, Dulac and Torello, 2003). These changes in
endocrine function can lead to the onset of puberty or the termination of pregnancy in
female mice upon detection of male pheromones (known as the Bruce Effect), while the
detection of female pheromones by female mice can cause a delay in the onset of puberty
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(Bruce, 1959, Bellringer et al., 1980). These pheromone regulated behavioral changes
initiated by the modification of the hypothalamic-pituitary axis hav b
h omo

ff c s” (

m

“ im

-Marcos, 2003).

Pheromone signaling can also lead to rapid behavior modification in mice (Dulac
and Torello, 2003). These modifications include the initiation of aggression, copulatory
behavior, and lordosis (a posture that demonstrates sexual receptivity), among others
(Dulac and Torello, 2003, Chamero et al., 2012). Removal of the mouse VNO severely
disrupts reproductive behavior so that mounting and lordosis are not preferentially
directed towards the opposite sex (Stowers et al., 2002, Samuelsen and Meredith, 2009).
Trpc2 (transient receptor potential cation channel 2) mutants lose some VNO
functionality, and along with it aggressive and territorial behaviors (Chamero et al.,
2012). The VNO also plays an important role in eliciting predator based defensive
behaviors in mice (Stowers et al., 2002, Chamero et al., 2012).
Despite its powerful influence among many mammals, it is widely accepted that
humans no longer have a VNO, although we still respond to pheromones through signal
reception in the MOE (

-Marcos, 2003, Wang et al., 2007, Chamero

et al., 2012). Regardless of the presence or absence of the VNO in humans, it remains an
important and dynamic organ to study as i
og i

io

ovi s “fu

m

vo u io of ch mic commu ic io ,” s w

i fo m io o

h

s informing on the

neural processing of the historically mysterious sexual and social behaviors of animals
(Chamero et al., 2012).
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The mouse VNO is a paired tubular structure at the tip of the nose that is encased
in a bony capsule (

-Marcos, 2003) (Figure 1). The lumen through

which substances move separates the non-sensory and sensory epithelia and is connected
to the nasal cavity by the vomeronasal duct (

-Marcos, 2003). On

the side of the non-sensory epithelium a large blood vessel runs the length of the VNO
lateral to the lumen (Dulac and Torello, 2003). This section of the tissue is also populated
by connective tissue and glands that underlie the ciliated non-sensory epithelium (Dulac
and Torello, 2003). The cilium of the non-sensory epithelium beats to help move material
in and out of the lumen of the VNO.

Figure 1. Sagittal view of a mouse head highlighting the location of the VNO and the
AOB. Apical and basal VSNs project their axons to the glomeruli of the anterior
(yellow) or posterior (red) AOB respectively. In turn, the AOB transmits to the bed
nucleus of the stria terminalis (BST), the bed nucleus of the accessory olfactory tract
(BAOT), the posteroventral medial amygdala (MePV), and the posteromedial
cortical amygdala (PMCo). The inset shows a diagram of a coronal section of the
VNO, showing the crescent-shaped sensory epithelium with the two major layers,
apical and basal. Reprinted from Trends in Neuroscience, 35(10), Chamero, P.,
Leinders-Zufall, T., & Zufall, F., From genes to social communication: molecular
sensing by the vomeronasal organ, 597-606, 2012 with permission from Elsevier.
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Substances arrive in the lumen of the VNO through a mechanism known as the
vasomotor pump. Meredith et al. (1980) first demonstrated that the blood vessels in the
vicinity of the hamster VNO serve as a pump that draws chemicals into the lumen. In
hamsters, this pump appears to be activated in response to any novel stimulus (Meredith,
1994). Ben-Shaul et al. (2010) found that a similar vasomotor pumping activity also
occurs in the mouse VNO to draw in potential signaling molecules. This vasomotor
pumping mechanism not only draws chemicals into the lumen for detection by the VSNs,
but leads to a release of ATP (Vick and Delay, 2012).
The crescent-shaped sensory epithelium, or neuroepithelium, of the VNO is
populated by vomeronasal sensory neurons (VSNs), supporting cells, and basal cells
(

-Marcos, 2003) (Figure 2). VSNs are bipolar cells that have a

single apical dendrite and dendritic knob that reaches to the surface of the lumen and an
axon that projects to the accessory olfactory bulb (AOB) (Dulac and Torello, 2003,
Ghiaroni et al., 2003, Chamero et al., 2012). The AOB is positioned on the dorsal
posterioregion of the olfactory bulb (Figure 1) (Chamero et al., 2012). The dendrites of
the VSNs end in dendritic knobs with microvilli that contain much of the chemosensory
machinery of the VNO including the V1R and V2R receptors and Trcp2 (Chamero et al.,
2012). These dendrites are bathed continually in fluid that is secreted from the VNO
glands at the ventral and dorsal tops of the lumen (Dulac and Torello, 2003). In isolation,
VSNs are identifiable by their large cell body and clear dendrite.
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Figure 2. A coronal section of the mouse VNO. The lumen (L), sensory epithelium
(SE), non-sensory epithelium (NSE), and the blood vessel (BV) are labeled for
reference. Within the sensory epithelium VSNs with dendrites reaching to the
luminal surface can be observed. DIC image taken with a 20x lens.

VSNs are noted to activate at current injections as low as 1 pA, which may help
account for their high sensitivity to chemical signals (Liman and Corey, 1996, Inamura
and Kashiwayanagi, 2000). Signal transduction in the VNO is largely dependent on
receptors in the dendritic knobs of the VNO. Upon activation by pheromones, receptors
such as V1R (in the apical layer) and V2R (in the basal layer) activate downstream signal
transduction mechanisms (Berghard et al., 1996, Holy et al., 2000, Ukhanov et al., 2007).
This includes the production of inositol-1,4,5-triphosphate (IP3) and diacylglycerol
(DAG) by phospholipase C (PLC) (Krieger et al., 1999, Dulac and Torello, 2003). The
increase in IP3 leads to a subsequent increase in intracellular Ca2+ that is released from
intracellular stores and influxes from extracellular sources, while DAG activates Trpc2
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which leads to an influx of Ca2+ and Na+ into the microvilli of the VSNs (Halpern and
Ma

-Marcos, 2003). The influx of Ca2+ can go on to stimulate calcium-activated

chloride current that amplifies the response of the VSNs (Yang and Delay, 2010, Kim et
al., 2011). As mentioned earlier, this signal transduction is carried by the axon to the
AOB, where the release of glutamate serves as the neurotransmitter to transmit the
information throughout the central nervous system (Dudley and Moss, 1995).
The VSNs share the neuroepithelium of the VNO with the supporting cells and
the basal cells. The supporting cells of the VNO are bipolar with cell bodies that lie close
to the luminal border, with short apical processes that reach the epithelial surface and a
long basal process that reaches to the basal lamina (Ghiaroni et al., 2003). It is possible
that supporting cells play a role in chemosensory activity of the VNO (Hassenklover et
al., 2008). They are notable for possessing voltage-gated ion channels that may play a
role in maintaining homeostasis of the tissue and regulating the chemical composition of
the intercellular fluid in a manner which supports the excitability of the VSNs (Ghiaroni
et al., 2003). The basal cells of the VNO lie along the basal lamina of the
neuroepithelium, and replace apoptotic VSNs through migration and differentiation
(Cappello et al., 1999, Giacobini et al., 2000). VSNs are continually undergoing
apoptosis and being replaced, even in adult animals (Giacobini et al., 2000). This ensures
rapid tissue repair following damage from the harsh environmental stimuli the VNO
comes in contact with in order to ensure that the tissues maintains optimum performance
(Giacobini et al., 2000).
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Purinergic Signaling
Purinergic signaling, a form of chemical communication in which a purine,
commonly adenosine tri-phosphate (ATP), adenosine di-phosphate (ADP), or adenosine,
serves as a signaling molecule through the excitation of P1 and P2 receptors, has become
an important area of study as purinergic signaling pathways have been found to be
widespread and have versatile functionality among mammals (Hegg CC, 2003,
Abbracchio et al., 2009, Housley et al., 2009). Purinergic signaling was first identified in
1972, when it was demonstrated that ATP was a neurotransmitter in the noncholinergic,
non-adrenergic inhibitory nerves of the guinea- ig’s

i co i (Burnstock, 1972).

Widespread acceptance of the hypothesis that purines could serve as signaling molecules
did not occur until the identification and cloning of purinergic receptors in the 1990s
(Burnstock, 2009). In the twenty years since, it has been determined that purinergic
signaling receptors are among the most abundant signaling receptors in mammals, having
been found in every cell and tissue type examined including nervous tissue (Burnstock
and Knight, 2004). ATP has been shown to be a transmitter or cotransmitter in nerves
throughout the peripheral and central nervous system (Abbracchio et al., 2009). It serves
as a fast excitatory neurotransmitter as well as a long-term modulator of growth and
development, cell proliferation, and cytotoxicity, making purinergic signaling a critical
and influential signaling system (Zimmermann, 2006, Burnstock, 2009).
There are three classes of purinergic receptors; G-protein coupled P1 adenosine
receptors, ionotropic P2X receptors, and G-protein coupled P2Y receptors (Burnstock,
2009). The adenosine receptors have been further split into four categories, A1, 2A, 2B,
and 3 (Burnstock, 2009). The ionotropic P2X receptors are designated P2X1-P2X7
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according to the seven distinct genes that code for the individual subunits of the trimer
that contains two transmembrane domains and a large extracellular loop (Nicke et al.,
1998, North, 2002, Roberts et al., 2006). They are classic ligand-operated ionotropic
channels that open upon binding of ATP, with a pore that is permeable to monovalent and
divalent cations, including Na+, K+ and Ca2+ (Ding and Sachs, 1999, Egan et al., 2006).
The monomer subtypes can form homomeric or heteromeric receptors, making them a
versatile form of receptor (Abbracchio et al., 2009).
While P2X receptors are activated primarily by ATP, P2Y receptors can be
activated by ADP, u i i

5′- i hos h

(UTP), u i i

5′-diphosphate (UDP), and

UDP-glucose (Abbracchio et al., 2009). These G-protein coupled receptors have the
classic seven transmembrane domains and are classified into two distinct P2Y subgroups:
the P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 subgroup and the P2Y12, P2Y13, and P2Y14
subgroup (Abbracchio et al., 2006). The first subgroup consisting of P2Y1, P2Y2, P2Y4,
P2Y6, and P2Y11 typically couples with the G-protein Gq/G11 to activate PLC, leading to
the release of IP3 and the subsequent release of intracellular Ca2+ from the endoplasmic
reticulum (Abbracchio et al., 2009). The second subgroup consisting of P2Y12, P2Y13,
and P2Y14 couples with G-protein Gi/o, which inhibits adenylyl cyclase and subsequently
modulates ion channel activity (Abbracchio et al., 2009). These purinergic receptors have
been extensively reviewed in (Abbracchio et al., 2009) and (Burnstock, 2009).
Purinergic Signaling in the VNO
Recently the role of purinergic signaling in the VNO has been studied in the lab
of Dr. Rona Delay through the use of electrophysiology, with results suggesting that
purinergic receptors play important functional roles in the VSNs. Purinergic signaling in
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the MOE has been more extensively reported in the literature. P2X and P2Y receptors are
expressed in the sensory epithelium of the mouse MOE, which upon reception of ATP
reduce the response of the olfactory sensory neurons (OSNs) while also increasing
intracellular [Ca2+] (Hegg CC, 2003). The ATP that serves as the signaling molecule in
this pathway is released upon exposure of the OSNs to high concentrations of odorants,
and induces basal progenitor cells to differentiate into OSNs to replace dead and dying
neurons (Hegg and Lucero, 2006, Hassenklöver et al., 2009). This suggests that in the
MOE purinergic receptors play a neuroprotective and neuroregenerative role by
preventing OSN toxicity and supporting differentiation.
However, the role of purinergic signaling in the VNO appears to be more varied.
Vick and Delay (2012) demonstrated that P2X receptors on isolated VSNs are activated
by ATP and elicited an inward current as well as a concentration-dependent increase in
intracellular [Ca2+](Figure 3). Vick and Delay (2012) also demonstrated that ATP
increased the response of VSNs to dilute urine. The study concluded that the release of
ATP upon mechanical stimulation of the VNO such as during activity of the vasomotor
pump led to P2X activation which may help regulate the chemosensory activity of the
organ (Vick and Delay, 2012). The release of purine nucleotides in a mechanosensative
manner has been well documented in many other tissues, including the retina, urinary
bladder, kidney nephron, epithelium of the lung, and the cochlea (Homolya et al., 2000,
Newman, 2001, Zhao et al., 2005, Sipos et al., 2009, Chen et al., 2010). While Vick and
Delay (2012) found that P2X receptor activation led to an increase in [Ca2+]i and an
inward current, the activation of P2Y receptors did not elicit a similar response. However,
the possibility remained that these purinergic receptors were present in the organ, and
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performing a yet unrecognized function. This hypothesis was supported by recent
unpublished data from Vick and colleagues that indicated a functional role for P2Y in
enabling persistent firing of VSNs (Figure 4).

Figure 3. Electrophysiological data from isolated VSNs demonstrating the role of
P2X receptors in generating the inward current elicited by ATP. (A) The partial
block of the inward current by PPADS indicated the P2X receptor is responsible for
the generation of the current. The normalized inward currents for each VSN tested
for this response can be seen in (B). (C) The block of the inward current with TNPATP again indicated that the P2X receptor is responsible. The normalized inward
currents for each VSN tested are plotted in (D). (E) RT-PCR demonstrated the gene
expression of P2X1 receptors (382 bp) and P2X3 receptors (252 bp) in the VNO.
L = ladder, + = experimental groups, − = control groups. Reprinted with permission
from Neuroscience, 220, Vick J.S. and Delay R. J., ATP excites mouse vomeronasal
sensory neurons through activation of P2X receptors, 341-350, 2012.
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Figure 4. The P2Y1 agonist ADP increased spike frequency in isolated VSNs at
relatively depolarized current injections without altering other characteristics of the
action potential. (A) The increase of spike frequency upon the application of ADP
can be clearly seen relative to baseline. (B) A quantification of the spike frequency
from the VSN in (A) revealed a reversible stabilization of the maximal rate of firing
at higher current injections. (C) The difference in the average percentage change in
spike frequency of control and ADP was statistically significant at 18 to 20pA of
current injection. (D) The schematic used to analyze each action potential’s
amplitude, latency, halfwidth, and threshold voltage with a custom made script
written in MatLab by Roman Popov. (E)-(H) The difference in the average
percentage change in latencies to first spike, amplitudes, halfwidths, and the
thresholds of the control and ADP were not statistically significant. Figure reprinted
with permission from Jonathan Vick.
Working from this data, the study herein aimed to continue the exploration of
purinergic receptors in the VNO by identifying gene expression of P2Y receptors in the
tissue and using methods of immunohistochemistry and immunocytochemistry to
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determine the immunolocalization of selected common P2Y and P2X receptors.
Immunohistochemistry in the literature has demonstrated that subsets of both receptors
have immunoreactivity with the VNO, but no immunocytochemistry has confirmed in
what cell types the expression occurs (Gayle and Burnstock, 2005). We hypothesized that
P2X and P2Y receptors would demonstrate gene expression in the VNO with
immunolocalization to the sensory epithelium, where ATP release via activity of the
vasomotor pump would activate the purinergic receptors and lead to subsequent
modulation of the VSN response. The immunolocalization and activity of this pathway in
the VNO would implicate purinergic signaling in the regulation of mammalian social and
sexual behaviors.
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MATERIALS AND METHODS
VNO Dissection
All experiments were performed with C57 BL/6 and BALB/C mice raised and
uh i

i

cco

c wi h h U iv si y of V mo ’s I s i u io

A im C

nd

Use Committee under IACUC protocol 07-094. Euthanasia was accomplished through
CO2 asphyxiation followed by cervical dislocation. After the animal was sacrificed the
VNO was immediately removed through dissection. The head was removed from the
body, cut bilaterally, and the VNO in the bony casing was extracted. The bony casing
was then removed in the presence of enzyme free dissociation solution (in mM: 140
NaCl, 10 HEPES, 10 Glucose, 5 KCl, 2 EDTA, pH. 7.4).
Reverse Transcription Polymerase Chain Reaction
To identify gene expression of selected P2Y receptors in the VNO reverse
transcription polymerase chain reaction (RT-PCR) was performed using primers for
P2Y1, P2Y2, P2Y4, and P2Y6 receptors. Primers were obtained from Integrated DNA
Technologies with sequences from del Ray et al. (2006) (Table 1). Total RNA was
isolated and purified from the VNO using Qiagen’s RN sy Mini Kit according to
m uf c u

’s i s uc io . The purity of the isolated RNA was tested using a NanoDrop

Spectrophotometer courtesy of the Vermont Genetics Network Proteomics Facility.
cDNA was synthesized with 200U SuperScript III Reverse Transcriptase
(Invitrogen) and 2.5 μM random hexamers (Applied Biosystems) with 2 μg of total RNA
in a volume of 20 μL. RNaseOUT (Invitrogen) was added to the reactions to prevent
degradation of the RNA by inhibiting ribonuclease. A negative control was performed by
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omitting SuperScript III Reverse Transcriptase in order to ensure that the PCR products
were produced from the cDNA rather than contaminants. The following conditions were
followed for cDNA synthesis: i. 25° C for 5 minutes, ii. 50° C for 30 minutes, iii. 55° C
for 30 minutes, iv. 70° C for 15 minutes, v. final hold at 4 ° C.
PCR was performed using 1 μL cDNA, 12.5 pmol forward and reverse primers,
2.5 mM MgCl2 (Invitrogen), 200 μM dNTPs (New England BioLabs), 10x PCR reaction
buffer (Invitrogen), and 1.25U Taq polymerase (Invitrogen) in a final volume of 25 μL.
The following conditions were followed for PCR: i. serial heating at 94° C for 5 minutes;
ii. amplification over 35 cycles at 94° C for 30 seconds and 72° C for 30 seconds; iii.
final hold at 4 °C.
The amplified products were resolved with gel electrophoresis with a 1% agarose
gel run at 130 mV for 30-60 minutes. The gel was stained with ethidium bromide for 3060 minutes and observed and photographed using a UV light box. PCR products were cut
out and purified from the agarose gels using Omega Bio-T k’s G Ex
according to manufactu

’s i s uc io s

s qu c

c io Ki

with the assistance of the

Vermont Genetics Network (http://www.vermontcancer.org/). Sequences were checked
with the basic local alignment search tool (BLAST) to confirm the product was that of
the desired purinergic receptor.
Immunohistochemistry
Immunohistochemistry was performed using antibodies for P2Y1, P2Y2, and P2X1
receptors as specified in Table 2. The dissected VNO was fixed in 4% paraformaldehyde
fixative in 0.1 M phosphate buffer solution for 1 hour and then rinsed twice in 0.1 M
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phosphate buffer. All rinses were accomplished by moving the tissue between the wells
of a 6-well plate. The VNO was then embedded in 15% gelatin in 0.1 M phosphate buffer
and returned to the 4% paraformaldehyde fixative for 1 hour. The tissue was then washed
6 times for 10 minutes each in 0.1 M phosphate buffer. In order to confer cryoprotection
the tissue was run through a graded sucrose solution consisting of 0.5 M, 1 M, 1.5 M, and
2 M sucrose in 0.1 M phosphate buffer solution. The VNO was sectioned with a Microm
HM505E cryostat at ~ –26° C to a thickness of 20 μm. Sections were placed in phosphate
buffered saline (PBS).
Selected sections were then transferred to wells of a 6-well plate, 4 sections to
each well, and washed in a preincubation buffer consisting of 6.5 % normal goat serum in
0.1 M phosphate buffer with 10% Triton-x-100 (Acros Organics) for 1 hour with mixing
at room temperature. The sections were then incubated in primary antibody for 24 hours
at room temperature with mixing. All antibodies were diluted in preincubation buffer.
The P2Y1 primary antibody was diluted to a concentration of 1:100, the P2Y2 primary
antibody was diluted to a concentration of 1:500, and the P2X1 primary antibody was
diluted to a concentration of 1:500, as detailed in Table 2. A negative control was
performed by incubating without primary antibody.
After primary incubation the sections were washed with PBS 6 times for 10
minutes each. They were then incubated with secondary goat anti-rabbit TRITC
conjugated antibody (Invitrogen) at a concentration of 1:1000 for 1 hour. The sections
were incubated in the dark at 4°C. Sections were washed with PBS and mounted with
Flouromount-G (Southern Biotek). Slides were stored in the dark at room temperature for
24 hours to allow the Flouromount to harden and then stored in the dark at 40 C.
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Sections were imaged with a Zeiss Axioskop2 microscope fitted with a
Photometrics CoolSnap EZ camera with NIS Elements used for image capture. Images
were obtained using 20x and 40x objectives, with care being taken to image control
sections with the same exposure as the experimental sections. All images were saved as
TIFF files and processed using the image processing package FIJI, also known as Image
J. Edited images were then saved as both TIFF files and JPEG files and a figure was
made using Adobe Photoshop.
Immunocytochemistry
Immunocytochemistry was performed using antibodies for P2Y1 and P2Y2
receptors as specified in Table 2. Isolated cells were obtained through either a
collagenase or papain digestion. The collagenase digestion was performed by
mechanically dissecting the VNO for 10 minutes in dissociation solution supplemented
with 1 mg/ml collagenase (Sigma) and 40 μL trypsin (Life Technologies). The digestion
solution was rotated for 1 hour before being transferred to a 1 mL eppendorf tube and
centrifuged at 4.8 RPM for 1 minute. The resulting cell pellet was then resuspended with
Ri g ’s so u io (i m : 138 N C , 5 KC , 10 EPES, 2

gC 2, 2 CaCl2, 10 glucose;

pH 7.4) supplemented with 1 mg/mL DNase (Sigma) and rotated for an additional 20
minutes. The resulting cell suspension was transferred to a test tube and gently triturated
for 2-3 minutes. The papain digestion was performed by placing the VNO in dissociation
solution supplemented with 10mg/mL papain (Calbiochem) for 10 minutes of mechanical
dissection. The solution was then transferred to a test tube containing Ri g ’s so u io
supplemented with ≈10 μg/mL u
triturated for 2-3 minutes.

i (USB) to inhibit papain and was gently
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The resulting cell suspension from either digestion was plated on round glass
cover slips coated with concanavalin A (Calbiochem). The cell suspension was allowed
to settle for 30 minutes before being fixed with 4% paraformaldehyde fixative in 0.1 M
phosphate buffer for 15 minutes. The cover slips were then rinsed with 0.1 M phosphate
buffer. Once plated, the cells were washed with preincubation buffer for 30 minutes. The
cells were then incubated with primary antibody for 24 hours at 4° C. P2Y1 and P2Y2
receptor primary antibodies were diluted in preincubation buffer to a concentration of
1:500 (Table 2). A negative control was performed by incubating without primary
antibody. After primary incubation the cells were washed with PBS 3 times for 5 minutes
each. Secondary incubation was then performed in the dark at 4° C with a secondary goat
anti-rabbit TRITC conjugated antibody (Invitrogen) at a dilution of 1:1000 for 1 hour.
The cells were then washed with PBS 2 times for 5 minutes each. A final wash in
distilled water was then performed before the cover slips were mounted with
Flouromount-G to avoid crystallization. The slides were stored in the dark at room
temperature for 24 hours to allow the Flouromount to harden before being stored at 4°C.
Isolated VSNs were imaged with a Keyence BZ-9000 Fluorescence microscope
with the associated BZ-II Analyzer. VSNs were identified by morphological
characteristics using phase contrast microscopy. Images were obtained using a 40x
objective with 68x magnification, with care being taken to image control slides with the
same exposure as the experimental slides. All images were saved as TIFF files and a
figure was made with Adobe Photoshop. Slide screening was also performed at 40x
magnification, with 20-30 VSNs being observed for each treatment.
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Name

Primer

Sequence

Approximate
Product Size (bp)

P2Y1

Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

5'- ATC AGC GCA CAC AGG TAC AG -3'
5'- AAT CAT TGG ACG TGG TGT CA -3’
5'- CAG GCC TGT GCA TAT GTG AG -3'
5'- GGC AAC AGC ACG TAC TTG AA -3'
5'- CCA CAT CAG GGG GAA CTA AG -3'
5'- CAA GGA GTC TGC ACT GGT CA -3'
5'- AAC CTG CCT TGA AAA CAA CG -3'
5'- TTA GCA GCA GTC GCT TGA AA -3'

200

P2Y2
P2Y4
P2Y6

200
200
200

Table 1. Primers for RT-PCR and their product sizes in base pairs (bp).
Antigen
Primary Antibody
P2Y1 Receptor
P2Y2 Receptor
P2X1 Receptor
Secondary Antibody
Goat Anti-Rabbit
TRITC Antibody

Host

Immunohistochemistry
Dilution

Immunocytochemistry
Dilution

Source

Rabbit
Rabbit
Rabbit

1:100
1:500
1:500

1:500
1:500
N/A

Alomone Labs
Alomone Labs
Alomone Labs

Goat

1:1000

1:1000

Invitrogen

Table 2. List of antibodies for immunohistochemistry and immunocytochemistry.
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RESULTS
P2Y1, P2Y2, and P2Y6 receptor transcripts are present in the mouse VNO
We performed RT-PCR in order to determine which P2Y receptor subtypes have
gene expression in the mouse VNO using primers for P2Y1, P2Y2, P2Y4, and P2Y6
receptors. Gene expression of P2Y1, P2Y2, and P2Y6 receptors was detected (Figure 5).
We observed the product band for each purinergic receptor at the expected locale of 200
base pairs. There was no gene expression of the P2Y4 receptor detected (data not shown).
Gene expression was confirmed with sequencing by the Vermont Genetics Network and a
basic local alignment search (BLAST). The BLAST results confirmed sequencing with
98%-100% matching identities (Supplemental Figure 1-3).
While the RT-PCR clearly indicated gene expression of the P2Y receptors, there
were two anomalies. The first is the band which can be observed at the bottom of the
P2Y1 gel (Figure 5). This does not indicate gene expression, but is rather a common byproduct of the PCR process known as a primer dimer. The other occurrence is the second
band present around 450 base pairs in the P2Y2 gel (Figure 5). This band was sequenced
and found to be mucin 5 subtype B, a gene that encodes for a mucosal protein unrelated
to purinergic signaling receptors. As the product band in the same gel at 200 base pairs
was sequenced and confirmed to be of the P2Y2 receptor, the presence of the mucin 5
subtype B band did not interfere with the results. When taken in conjunction with the
results of the RT-PCR performed by Vick and Delay (2012), there is now supporting
evidence for gene expression of P2X1, P2X3, P2Y1, P2Y2, and P2Y6 receptors in the
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mouse VNO. These results support the hypothesis that there is purinergic receptor
expression in the mouse VNO.
Localization of purinergic receptors to the sensory epithelium of the VNO
The sensory epithelium of the VNO showed strong immunoreactivity to the P2Y1,
P2Y2, and P2X1 receptor antibodies with immunohistochemistry (Figure 6). The P2Y1
receptor antibody exhibited immunoreactivity throughout the sensory epithelium, with
particularly intense staining at the apical edge and within the supporting cell layer. The
dendrites and the dendritic knob region of the sensory epithelium appeared to be
particularly immunoreactive. The cell bodies of the VSNs were also clearly
immunoreactive. However, as indicated by the dotted appearance of the staining
throughout the sensory epithelium where the cell bodies of the VSNs are located, the
P2Y1 receptor antibody did not stain all VSNs but rather demonstrated selectivity. The
lack of immunoreactivity in the negative control for the P2Y1 receptor antibody
suggested that the staining observed in the sensory epithelium was specific.
The P2Y2 receptor antibody exhibited more uniform immunoreactivity with
strong staining throughout the sensory epithelium of the VNO (Figure 6). The dendritic
knobs at the apical edge again showed the most intense labeling, with the VSN cell
bodies showing strong and consistent staining throughout the tissue sections. The basal
lamina region also showed significant immunoreactivity to the P2Y2 receptor antibody.
Of particular interest was the staining pattern in the supporting cell layer of the sensory
epithelium which displayed a unique pattern of speckling upon close inspection. The

PURINERGIC SIGNALING RECEPTORS IN THE VNO 25

negative control for the P2Y2 receptor antibody suggested that the staining observed in
the sensory epithelium was specific.
The immunohistochemistry for the P2X1 receptor antibody also displayed
immunoreactivity throughout the sensory epithelium (Figure 6). There was staining
present throughout the cell bodies of the VSNs, while the dendritic regions of the
epithelium again demonstrated the most intense labeling. However, there was minimal
immunoreactivity in the basal lamina and supporting cell layers. The negative control for
the P2Y2 receptor antibody again indicated that staining observed in the sensory
epithelium was specific.
Localization of purinergic receptors to the non-sensory epithelium of the VNO
In addition to the immunoreactivity that was present throughout the sensory
epithelium, there was also immunoreactivity for the P2Y1, P2Y2, and P2X1 receptor
antibodies present on the ciliated non-sensory epithelium (Figure 6). The
immunoreactivity was uniform throughout the epithelium for all three receptor
antibodies, and the negative controls indicated that the staining was specific. It is
probable that purinergic receptors, as has been demonstrated by their ubiquitous presence
in every cell and tissue type so far examined, are also present in that non-sensory
epithelium of the VNO.
Localization of purinergic receptors to the glandular tissue of the VNO
Similar to the staining observed on the non-sensory epithelium, there was strong
immunoreactivity for the P2Y1, P2Y2, and P2X1 receptor antibodies in the glandular
tissue of the VNO (Figure 6). However, the negative controls for the P2Y1, P2Y2, and
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P2X1 receptor antibodies indicate that the staining may be largely nonspecific.
Localization of purinergic receptors to the VSNs
Immunocytochemisty was performed with P2Y1 and P2Y2 receptor antibodies
based on antibody availability. Twenty to thirty isolated VSNs were identified
morphologically by a rounded cell body, elongated dendrite, and a dendritic knob for
each antibody tested and representative isolated VSNs were imaged (Figure 7). Strong
immunoreactivity was noted in approximately 60%-70% of the VSNs observed.
Immunoreactivity was observed in the cell body, dendritic knob, and dendrite for both the
P2Y2 and P2Y1 receptor antibodies. The negative controls show a lack of
immunoreactivity.

Figure 5. RT-PCR demonstrating gene expression of P2Y1, P2Y2, and P2Y6 in the mouse
VNO. The expected product size for all primers was approximately 200 base pairs
(bp). L = ladder, + = experimental groups, − = control groups.
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Figure 6. Immunohistochemisty demonstrating the immunoreactivity to P2Y1, P2Y2,
and P2X1 receptor antibodies in the mouse VNO. Images were obtained at 20x and
40x magnification with a TRITC filter. Negative controls are also shown.
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Figure 7. Immunocytochemisty demonstrating the immunoreactivity to P2Y1 and
P2Y2 receptor antibodies in isolated VSNs. VSNs were identified by morphology.
Images were obtained at 68x magnification with phase contrast (PC) and a TRITC
filter. Negative controls are also shown.
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DISCUSSION
My results strongly support the hypothesis that there are purinergic receptors
demonstrating gene expression and immunolocalization in the mouse VNO. The
localization of purinergic receptors to the sensory epithelium of the VNO suggests a role
for purinergic signaling that is supported by previous electrophysiological data (Vick and
Delay, 2012). The results of the RT-PCR have supplemented the list of purinergic
receptors that have been demonstrated to have gene expression in the VNO of mice.
While P2X1 and P2X3 receptors were shown to have gene expression in the VNO by
Vick and Delay (2012), this study was able to add P2Y1, P2Y2 and P2Y6 to that list. This
is the first RT-PCR evidence that P2Y receptors are present in the VNO, supporting our
hypothesis and suggesting the possibility that there are a wide range of purinergic
receptors present in the organ. To the best of our knowledge, this is also the first study to
demonstrate the immunolocalization of purinergic receptors to the VSNs, with the
localization of P2Y receptors to the cell bodies and dendritic regions. The
immunolocalization of the purinergic receptors to the VSNs and throughout the tissue of
the VNO indicates that purinergic receptors may play a wide range of functional roles in
the organ, including modulation of pheromone sensory detection and transduction,
motilary function, mucocous secretion, and the maintenance of homeostasis.
The immunolocalization of the purinergic receptors P2Y1, P2Y2, and P2X1 to the
sensory epithelium of the VNO supports the hypothesis that purinergic signaling
receptors in the VNO play a role in the chemosensory activity of the organ. The
immunocytochemistry results that demonstrate immunolocalization of P2Y1 and P2Y2
receptors to the VSNs further support this hypothesis. The results closely match what
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Gale and Burnstock (2005) observed, with immunoreactivity of the VNO to the P2Y1 and
P2Y2 receptor antibody. They saw particularly strong staining in the luminal face of the
VNO as we did, as well as staining that extended through the entire epithelium. The
immunolocalization of the purinergic signaling receptors to the sensory epithelium and
VSNs strongly suggests that they play a role in signal transduction. Interestingly, the
receptors are seen to be on the cell body as well as the dendrite, while the V1R/V2R
receptors are localized to the dendritic knob. This suggests that the purinergic receptors
may be playing a role in maintaining the homeostasis of the cell through activity in the
cell body, which modulates it excitability and responsiveness to pheromone signaling. As
hypothesized by Vick and Delay (2012), it is also possible that the purinergic receptors,
particularly those immunolocalized to the dendritic knob of the VSNs, respond to
nucleotides released upon activation of the vasomotor pump that draws material into the
lumen of the VNO. The activation of the purinergic receptors may prime the VSNs for
pheromone signal transduction, or perhaps work to maintain optimal operating conditions
for VSN activity upon the reception of material in the lumen of the VNO by way of the
vasomotor pump. Further study is necessary to fully understand this effect.
The immunolocalization of the purinergic receptors to the nonsensory epithelium,
particularly the ciliated epithelium and the glandular epithelium, illustrates the multiple
functional roles of purinergic receptors. These results suggest that in the VNO alone they
may play multiple functional roles, aiding in the chemosensory activity of the organ both
through movement of the signaling molecules into and through the lumen and in the
VSNs themselves, modulating and maintaining signal transduction. Gayle and Burnstock
(2005) also observed that the purinergic receptor immunoreactivity was not limited to the
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sensory epithelia. The presence of immunoreactivity of P2Y1, P2Y2, and P2X1 in the
ciliated epithelium of the VNO suggests that the purinergic receptor may play a role in
the locomotion of cilia and the movement of signaling molecules into and around the
lumen of the organ, in order to ensure contact with the sensory epithelium. An increase in
ciliary activity was noted in frog epithelium upon contract with increasing concentrations
of ATP (Ovadyahu et al., 1988). Similarly, Winters et al. (2008) found that ciliary beat
frequency was increased upon activation of P2Y2 receptors in the mouse trachea. When
the vasomotor pump is activated and ATP is released, it is possible that activation of the
purinergic receptors on the ciliated epithelia results in increased activity in a similar
manner. This would conserve energy by ensuring that the ciliated epithelium is only
active when needed to move fresh material into and around the lumen of the VNO.
The expression of purinergic receptor antibodies in the glandular tissue of the
VNO may also be significant. Not only does it further highlight the extreme diversity of
function that the purinergic receptors encompass, but it is also suggests that purinergic
signaling in the glandular tissue has an impact on the activity of the VNO. The glandular
tissue of the VNO secretes mucous that helps move the pheromone signaling molecules
throughout the lumen and lubricates the epithelia (

-Marcos, 2003).

However, a study of the rat VNO hypothesized that the glandular tissue of the VNO
could also be modulating sensory responses through endocrine functions (Lee et al.,
2008). Lee et al. (2008) found signaling proteins and mechanisms in the glandular tissues
of the VNO, suggesting that the glandular tissues may modulate the chemosensory
activity of the VNO by altering the responsiveness of the VSNs in correlation with
hormonal status. It is possible, although much study would need to be performed to
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address the hypothesis, that the purinergic receptors immunolocalized to the glandular
tissue of the VNO may play a role in the chemosensory activity of the tissue beyond
excretion of mucus to lubricate the epithelia and transmission of pheromones.
Additionally, the immunoreactivity of the P2Y receptor antibodies to the
supporting cell layer of the VNO is indicative that the supporting cells are expressing
purinergic signaling receptors in addition to the VSNs. In many other areas of the
nervous system, glial and supporting cells have been demonstrated to play an active role
in purinergic signaling pathways, expressing many of the receptors (Neary et al., 1996,
Brass et al., 2012, Vitanova and Kupenova, 2014). In the MOE, supporting cells express
purinergic receptors that upon activation by ATP leads to Ca2+ responses and gap
junction opening (Vogalis et al., 2005, Czesnik et al., 2006). It has already been
suggested that the supporting cells of the vomeronasal organ play an important role in the
chemosensory activity of the VNO by potentially mopping-up excess K+ and Na+ in the
lumen and sensory epithelia in order to maintain homeostasis and optimal VSN activity
(Ghiaroni et al., 2003). With this evidence of purinergic receptors in the area of the
supporting cells, there may be even more layers of complexity to the activity of the
supporting cells that should be further explored, as it is possible that they play an
important role in modulating the chemosensory activity of the VNO.
However, the presence of purinergic receptors in the VNO suggests functional
roles that may go far beyond modulation of chemosensory transduction. Purinergic
receptors have been demonstrated to exert multiple functional roles in sensory systems,
including controlling the development, remodeling, and regeneration of the systems
(Zimmermann, 2006). In other areas of the nervous system purinergic receptors play a
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role in trophic actions, regulating neuronal survival, growth, and apoptosis (Neary et al.,
1996). ATP released from injured cells in the MOE leads to activation of P2 receptors on
the sensory neurons, supporting cells, and basal cells, initiating protective responses and
stimulating progenitor basal cell proliferation to regenerate damaged tissue (Housley et
al., 2009). In other areas of the nervous system, it has been demonstrated that when nerve
growth factor and P2Y receptors are co-activated, neuronal survival and growth is upregulated (Arthur et al., 2006). In another study, activation of P2Y1 and P2Y2 receptors
resulted in an increase of progenitor cell proliferation, leading to neurogenesis and
remodeling (Zimmermann, 2006). It is possible that the P2Y receptors that have been
identified in the VNO may be playing a role in the growth, development, and
regeneration of the organ. Furthermore, the immunolocalization of P2Y1 and P2Y2
receptors in the VSNs would place them in an ideal position for this activity.
These results can serve as the basis for a wide range of future study on the topic
of purinergic signaling in the VNO. To continue the line of inquiry it will be important to
further identify P2 as well as P1 receptors that are present in the VNO. This study
explored a few common purinergic signaling receptors, leaving many others to be
investigated. The acquisition of specific antibodies to explore the immunolocalization of
these receptors will be important to this process. In this study it was not possible to
successfully explore the immunolocalization of the P2X3 receptor due to the nonspecific
nature of the antibodies available. This was unfortunate as previous studies have
indicated strong immunoreactivity of P2X3 in the mouse VNO (Gayle and Burnstock,
2005). Identifying and acquiring specific antibodies will be crucial to the further study of
immunolocalization of purinergic receptors. With these antibodies at hand,
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colocalization experiments with other cellular molecules such as Ga/o will be possible to
determine what signaling mechanisms the purinergic receptors are interacting with. In
conclusion, while there is still much to be explored on this topic, this study has
demonstrated that there are purinergic signaling receptors present in the mouse VNO.
The immunolocalization of these receptors strongly supports the hypothesis that the
receptors are playing an active role in the modulation of the chemosensory activity of the
organ, and therein playing a role in the regulation of social and sexual behavior of the
mammal.
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